The Global Ophthalmic Ultrasound Systems Market is projected to grow at a CAGR of 8.16% during the forecast period to reach US$4.670 billion by 2029, from US$2.700 billion in 2022.
Ophthalmic ultrasound systems are advanced medical devices employed in ophthalmology for diagnostic imaging and therapeutic applications. Utilizing high-frequency sound waves, these systems generate detailed visuals of the eye’s internal structures, including the cornea, lens, vitreous humor, and retina. They excel in scenarios where traditional methods like optical coherence tomography (OCT) or fundus photography fall short, such as in cases of media opacities or obscured posterior segment views.
These systems are instrumental in diagnosing and managing eye conditions like retinal detachment, intraocular tumors, vitreous hemorrhage, and glaucoma. Ultrasound biomicroscopy (UBM), a specialized technique, provides high-resolution imaging of anterior segment structures, such as the iris, ciliary body, and angle, enhancing precision in complex cases. In 2025, advancements in portable ultrasound devices and AI-integrated imaging are improving diagnostic accuracy and accessibility in ophthalmology practices.
Ophthalmic ultrasound systems are vital for comprehensive ocular evaluations, supporting early detection and treatment of eye diseases. By integrating cutting-edge technologies like real-time imaging and 3D visualization, these systems are driving better patient outcomes and revolutionizing eye care, particularly in regions with growing healthcare infrastructure like North America, Europe, and the Asia-Pacific.
The increasing predominance of optical illnesses like nearsightedness, hyperopia, astigmatism, and presbyopia around the world is predicted to boost the ophthalmic ultrasound systems market expansion within the estimated period. For instance, as per the World Health Organization's data of October 2021, around 2.2 billion people globally endure close or far-off vision disability, approximately 1 billion cases being preventable or however to be tended to.
Besides, the WHO evaluated that around 826 million individuals around the world are affected by unaddressed presbyopia. Refractive errors, age-related macular degeneration, cataracts, and glaucoma are recognized as the major causes of vision disability and visual impairment all over the world, with vision loss influencing people of different ages, though predominantly those above fifty years of age. These discoveries emphasize the expanding burden of eye illnesses universally, driving the demand for ophthalmic ultrasound devices, which are pivotal for diagnosing such conditions.
The prevalence of diabetic retinopathy is one of the major causes for the market expansion in the year ahead. For instance, recent data from the American Academy of Ophthalmology indicates that there are around 387 million individuals worldwide living with diabetes mellitus in the year 2016, which is expected to expand to 592 million by 2035.
Additionally, diabetic retinopathy affects approximately 93 million individuals globally. Among individuals with type 1 diabetes, the prevalence of diabetic retinopathy is 77.3%, while for those with type 2 diabetes, it is 25.1%. It is estimated that 25% to 30% of type 2 diabetes patients will develop vision-threatening diabetic macular edema. Laser therapy is required for 5% to 8% of patients with diabetic retinopathy.
Variables like increasing awareness, rising disposable incomes, a developing elderly population, and the predominance of eye conditions are growing market extensions within North America. Several research article highlights on the predominance of visual impairment and other visual disorders.
For illustration, there are around 12 million adults that are aged forty and over in the US who have vision loss that cannot be rectified, with over 1 million of them classified as blind. It is anticipated that the number of blind people will surge to 8.96 million by 2050, to a great extent due to the rising prevalence of diabetes and other chronic ailments, as well as the elderly population within the United States. Besides, the Centers for Disease Control and Prevention (CDC) reports that about 3% of children below the age of 18 years encounter visual impairment or blindness.
The rise in undiagnosed target diseases is additionally anticipated to contribute to market expansion.
Further, the Ontario Association of Optometrists article in July 2021 stated the effect of Canada's aging population on the predominance of corrected vision. The report shows that 1.2 million Canadians encounter vision loss, with 466,000 dwelling in Ontario alone.
Moreover, over 8 million Canadians, about 3.1 million in Ontario, are influenced by one of the four fundamental eye illnesses (age-related macular degeneration, glaucoma, diabetic retinopathy, and cataracts), putting them at risk of vision loss or already encountering it. The expanding predominance of eye disorders is anticipated to drive the share of the ophthalmic ultrasound systems market and hence fuel industry expansion.
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Market Size Value in 2022 | US$2.700 billion |
| Market Size Value in 2029 | US$4.670 billion |
| Growth Rate | CAGR of 8.16% from 2022 to 2029 |
| Study Period | 2019 to 2029 |
| Historical Data | 2019 to 2022 |
| Base Year | 2023 |
| Forecast Period | 2024 – 2029 |
| Forecast Unit (Value) | USD Billion |
| Segments Covered |
|
| Companies Covered | |
| Regions Covered | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| Customization Scope | Free report customization with purchase |
Ophthalmic Ultrasound Systems Market is segmented and analyzed as below: